Distributors and OEM brands are scrutinizing their supply chain to ensure quality and viability over the long term as the ...

The consequences of President Trump's actions on drug pricing continue to play out, with Bristol Myers Squibb insisting it will charge the same in the UK for new schizophrenia drug Cobenfy as in the ...

Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...

In a situation of such high stakes, Yichun Dawnice Manufacture and Trade Co., Ltd., as a leading 48V Lithium Battery Factory ...

Solarvest Holdings Bhd's near-term earnings contribution is expected to be modest at about RM1mil to RM2mil, but its ...

The arbitrage scanners market is saturated with dozens of solutions, yet only a few stand out in terms of speed, coverage, ...